A hepatitis B- és D-vírus-ferto{combining double acute accent}zés diagnosztikája, antivirális kezelése: Magyar konszenzusajánlás

Translated title of the contribution: Diagnosis and treatment of chronic hepatitis B and D: Hungarian national consensus guideline

Gábor Horváth, Zsuzsanna Gerlei, Judit Gervain, Gabriella Lengyel, Mihály Makara, Alajos Pár, László Rókusz, Ferenc Szalay, László Telegdy, István Tornai, Klára Werling, Béla Hunyady

Research output: Contribution to journalArticle

3 Citations (Scopus)


Diagnosis and treatment of hepatitis B and D virus infections mean that the patient is able to maintain working capacity, increase quality of life, prevent cancer, and prolong life expectancy, while the society benefits from eliminating the chances of further transmission of the viruses, and decreasing the overall costs of serious complications. The guideline delineates the treatment algorithms for 2015, which is agreed on a consensus meeting of specialists involved in the treatment of the above diseases. The prevalence of hepatitis B virus infection in the Hungarian general population is 0.5-0.7%. The indications of treatment is based upon viral examinations (including viral nucleic acid determination), determinations of disease activity and stage (including biochemical, pathologic, and/or non-invasive methods), and excluding contraindications. To avoid unnecessary side effects and for cost-effective approach the guideline emphasizes the importance of quick and detailed virologic evaluations, the applicability of transient elastography as an acceptable alternative of liver biopsy in this regard, as well as the relevance of appropriate consistent follow up schedule for viral response during therapy. The first choice of therapy in chronic hepatitis B infection can be pegylated interferon for 48 weeks or continuous entecavir or tenofovir therapy. The latter two must be continued for at least 12 months after hepatitis B surface antigen seroconversion. Adefovir dipivoxil is recommended mainly in combination therapy. Lamivudine is no longer a first choice; patients currently taking lamivudine must switch if response is inadequate. Appropriate treatment of patients taking immunosuppressive medications is highly recommended. Pegylated interferon based therapy is recommended for the treatment of concomitant hepatitis D infection.

Translated title of the contributionDiagnosis and treatment of chronic hepatitis B and D: Hungarian national consensus guideline
Original languageHungarian
Pages (from-to)25-35
Number of pages11
JournalOrvosi hetilap
Publication statusPublished - Mar 1 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Diagnosis and treatment of chronic hepatitis B and D: Hungarian national consensus guideline'. Together they form a unique fingerprint.

  • Cite this